The U.S. CRISPR & Cas Genes Market is emerging as a vital component of the country's biotechnology ecosystem, driven by continuous innovation in genetic engineering and precision medicine. The increasing adoption of genome editing technologies across research laboratories, pharmaceutical companies, and biotechnology organizations is accelerating the development of targeted therapies for...